AusBiotech is offering a list of optional activities for Tuesday 23 May. You can opt in for one of the options below during the registration process


Medical Technology Research Institute Tour*

10:00am - 4:00pm

The Medical Technology Research Institute Tour will explore some of the world’s leading medical research institutes including the Bionics Institute, the St Vincent's Institute of Medical Research and the newly-developed Aikenhead Centre for Medical Discover (ACMD) research facility, BioFab3D@ACMD. Together these institutes provide a unique model for collaboration between researchers, clinicians, end-users and industry in Melbourne’s CBD.

This tour will provide the opportunity to:

  • Visit cutting-edge institutes and centres
  • View research, facilities and capabilities within Melbourne’s CBD
  • Meet academics driving the latest medical technology research

*The tour is not included in the conference registration. You can register for the tour during the registration process for an additional $15


Inaugural ANDHealth AusBiotech Digital Health summit

Location: Allens Linklaters, 101 Collins St, Level 37, Melbourne, 3000, VIC

8:30am - 6:30pm

ANDHealth, Australia’s national digital health integrator and accelerator, is running a one-day digital health summit in conjunction with AusBiotech on 23 May. Join the community for excellent networking sessions between speakers:


  • Hear practical information and insights from the leaders in digital health;
  • Investor perspectives;
  • Company success stories;
  • Regulatory information; and
  • Access to Australia’s leading digital health entrepreneurs.


View the full program and register here

Regulatory affairs and health economics workshop

Location: TBC

9:30am - 5:30pm

AusMedtech, the national industry group representing the medical devices and diagnostics industry sector in Australia, invites you to attend the Regulatory Affairs and Health Economics Workshop at AusMedtech 2017 & ICMMB 2017.

While Australia boasts a strong market for developing medical technology, yet the landscape is complex and dynamic. This workshop will explore this landscape, presenting current trends and emerging issues that may affect organisations operating in the medical device industry.

The AusMedtech Regulatory Affairs Expert Panel will lead the morning session, focusing on the Therapeutic Goods Administration (TGA)’s Medicines and Medical Devices Review (MMDR), changes in the European Union (EU) and provide an overview of risk classification.

The afternoon session, led by the Health Economics Expert Panel, will discuss prostheses prices and continuing reform of private health insurance. 

View the full program and register here


Phillips Ormonde Fitzpatrick wine tasting event

6:00 - 8:00pm

Enjoy a relaxed evening of wine tasting, followed by a networking session hosted by Phillips Ormonde Fitzpatrick at their Melbourne office 

Express your interest, spaces are limited

9:00 - 9:30am

Arrival and registration for AusMedtech 2017 & ICMMB 2017

9:30 - 10:00am 
Official conference welcome


Glenn Cross, AusBiotech, CEO

Yosry Morsi, ICMMB Chair

Host state partner welcome

10:00 - 11:00am


Plenary: The Bionic Eye: Restoring sight with vision prostheses

The bionic eye aims to deliver functional vision and improved quality of life for patients with degenerative vision loss caused by conditions such as retinitis pigmentosa and age-related macular degeneration. This talk will present recent developments and the challenges associated with providing clinically safe and commercially competitive technologies to provide functional everyday benefits to patients. The Bionic Vision Australia research program, which has developed a fully implantable device that is based upon the successful prototype study with three patients, will be outlined.


Prof Anthony N Burkitt, Director, Bionic Vision Australia, University of Melbourne 

11:00 - 12:00pm


 Plenary: We are such stuff as dreams are made on

The concept of harnessing the power of science and technology to deliver personalised medical solutions for trauma, tumour, degeneration, and disease has become an irresistible quest that has galvanised scientists and clinicians. The rapid advances in technology has enabled scientific discovery, greater innovation and more significant impact of treatments.


Prof Peter Choong, Sir Hugh Devine Professor of Surgery, University of Melbourne Director of Orthopaedics, St. Vincent’s Hospital Melbourne

12:00 - 1:00pm

Lunch and networking with exhibitors

‘Meet the AusMedtech Regulatory Affairs Expert Panel’ networking lunch 


AusMedtech breakout sessions

ICMMB breakout sessions

1:00 - 2:00pm

Emerging technologies

From professional kitesurfing to human exoskeletal design, from skin patrol to digital health, and from the first female President of the Medical Software Industry Association to cloud based chronic disease management, these 3 speakers will share the insights of their journey and the development of some very exciting emerging technologies


Chair: Warren Bingham, VP Asia Pacific, Clinical Genomics


Dr Gil Stynes, Department of Surgery, St. Vincent’s Hospital, University of Melbourne

Jenny O’Neill, CEO and co-founder, Episoft 

Samuel Holt, Founder, Skinview

Regulatory Affairs

Implementation of recommendations from the Review of Medicines and Medical Devices Regulation report


A/Prof John Skerritt, Deputy Secretary, Health Products Regulation Group, Department of Health 

Biomaterials and Tissue Engineering - Part 1


Keynote speaker: Prof Shengmin Zhang, Huazhong University of Science and Technology


Tonghe Zhu, Donghua University, Shangai, China

Braid-Reinforced Nanofibrous Small Diameter Vascular Grafts for Potential Vascular Tissue Reconstruction


Prof Simon Moulton, Swinburne University of Technology, Australia

Biofabrication for drug delivery

Advances in Stem Cell Therapies – Part 1


Keynote speaker: Prof Samira Musah, Harvard University (USA)

Stem cell-based model of human organ development and function


Prof Ramakrishnan Swaminathan, Indian Institute of Technology, India

Analysis of fatigue on biceps brachii muscles using SEMG signals and spline chirplet transform 



Business models for medical technologies


Chair: Peter Bradley, VP Global Business Development, LBT Innovations  


Phoebe Macleod, Head of Legal and Licensing, Digital Health, MCRI 


Nick Haan, Executive Director, OncoDx

Medical device clinical trials: Developments in the Australian landscape


Chair: Lorraine Chiroiu, Deputy CEO, AusBiotech


Sue MacLeman, CEO & Managing Director, MTPConnect

Measuring the economic value of CTs: MTPConnect's work to support the Industry


Lyndon Crossley, Director of Clinical affairs, Global Orthopaedic Technology

The evolving nature of CTs for post-market regulation and reimbursement in light of new technologies


Adele Hosseini, Director of Clinical Affairs

The new normal: Case study on CTs in non-typical circumstances


Kylie Sproston, Chief Executive, Bellberry Limited

NHMRC National Scientific Committees & their role with clinical trials


Dr David Lloyd, Managing Director, Southern Star Research

Future Outlook for CTs in Australia


Biomaterials and Tissue Engineering - Part 2


Keynote speaker: Prof Yasuhiko Tabata, Kyoto University, Japan

Tissue Engineering of Biomaterials Technology to Realize Regeneration Medicine 


Lilith Caballero Aguilar, Swinburne University of Technology, Australia

Preparation and characterization of Polycaprolactone- Alginate microspheres for drug delivery


Shaun Gietman, Swinburne University of Technology, Australia

Synthesis of Optically Active Drug Delivery Systems 

Medical, Rehabilitation robotics and Assistive Devices-Part 1


Keynote speaker: Prof Romano Zannoli, University of Bologna, Italy

When you need, it never works : incongruence between technological solutions and clinical  needs


Dr Boyin Ding, The University of Adelaide, Australia

The impact of 6DOF loading speed on the viscoelastic behaviour of the femur 


Pier Luca Rossi, University of Bologna, Italy

Mechanical and radiological aspects of carbon dioxide coronal angiography: a study of feasibility

3:00 - 3:45pm

Afternoon tea and networking with exhibitors

3:45 - 4:45pm

Overcoming barriers to Global market access

Barriers to overcome to access market:

- Regulatory / Clinical trials

- Re-imbursement

- Distribution

- Cultural barriers


Chair: Brendan Mason, Managing Director, Sino-Oz 


Johanna Wright, Director of Regulatory Affairs, ResMed


Simranjit Singh, General Manager, Medical Devices & Diagnostics Asia, QuintilesIMS


Mike Heyl, Partner, Hogan Lovells



Is the Company Investable?

IP and Related Issues from Company, Investor and Adviser Perspectives


Chair: Rob McInnes, Partner, DibbsBarker


Peter Franke, Principal, Franke Hyland


Brigitte Smith, Managing Director, GBS Venture Partners


Dr Abby Bloom, Executive Chair, Acu Rate Pty Ltd 


Electrospinning– Part 1


Keynote speaker: Prof Xiumei Mo, Donghau University, China

Electrospun 3D Porous Nanofiber Scaffolds for Ligament and Cartilage Tissue Engineering


Riyadh Al-Attabi, Swinburne University of Technology, Australia

The use of electrospun nanofibers membranes for the removal viruses and bacteria from air 

Neuroscience and Neuroengineering - Part 1


Keynote speaker: Prof Rikky Muller, University of California, USA


William Hart, Swinburne University of Technology, Australia

Modelling the Optical Stimulation of Nerve Electrical Activity


Vidhusha, SSN College of Engineering, India

Speech Imagery based Vowel Classification using Brain Connectivity Estimators and Machine Learning Techniques 

4:45 - 5:45pm

Delivering on the potential of digital health

Digital health is creating a buzz but can it deliver on its potential? Hear about how these organisations are approaching digital health and realising its promise across pharmaceuticals, research and healthcare delivery


Adam Wardell, Head of Strategy, Innovation and BD&L, Novartis


Dr Rob Grenfell, Health Director, CSIRO Health and Biosecurity


The policy and politics of reimbursement of medical devices in Australia


Chair: Dominic Tilden, Director, Thema Consulting


Keynote speaker: Andrew Stuart, Deputy Secretary of Health Benefits Group, Department of Health 

Medical, Rehabilitation robotics and Assistive Devices - Part 2


Keynote speaker: Prof Yosry Morsi, Swinburne University of Technology, Australia 


Eric Wu, University of Queensland, Australia

Talking Heart to Heart: Towards an Intelligent Rotary Blood Pump


Shih-Yun Lin, National Cheng Kung University, Taiwan

Design and Stiffness Analysis of New Designed Rocker Shoe Soles 


Ivan Corazza, University of Bologna, Italy

Low Gradient severe aortic stenosis: how is it possible?


Biomechanics and Computer modeling/simulation-Part 1


Fernando Jativa, University of Melbourne, Australia

Biomechanics and functionality of human lung 3D smooth muscle and fibroblast spheroids 


Ashish Saxena, Nanyang Technological University, Singapore

Venous blood flow characterization in a human forearm 

Biomechanics and Computer modeling/simulation-Part 1

5:45 - 7.00pm

Iverson Health Innovations Research Institute Launch Event - Pre-Dinner Drinks

Supported by:



7:00 - 10:00pm

AusMedtech Cook Conference Dinner




7:45 - 8:45am

Australian National Fabrication Facility business breakfast

8:30 - 9:00am

Registration desk opens

9:00 - 9:45am

CEOs' session: What keeps you awake at night


Chair: Lusia Guthrie, Chairman, Clever Culture Systems


Peter Rowland, Managing Partner, Micro-X Ltd


Michael Kavanagh, CEO and President, Nanosonics


Stuart Elliott, CEO, Planet Innovation


Matthew Hoskin, CEO, Sienna Cancer Diagnostics 


Jacqui Savage, CEO & Founder, MedCorp Technologies

ICMMB Plenary


Keynote speaker: Dr Cheng-Kung Cheng, Chair Professor of Department of Biomedical Engineering and Director of Orthopaedic Device Research Center, National Yang Ming University; Chairman, Board of Directors of Digital Orthopaedic Foundation of Chinese Speaking Orthopaedic Society

Translational Research of Biomechanics: From Clinical Observations to Clinical Solutions 

9:45 - 10:20am


BTF panel update on the Biomedical Translation Fund

The Biomedical Translation Fund (BTF) is designed to support biotech through the two funding “valleys of death”, providing $500 million to be invested in the biotech sector. With the recent announcement of BTF fund managers, this panel will provide an update and explore how the BTF will stimulate private sector investment


Peter Wills AC, Chair, BTF Committee  


Anne-Marie Birkill, General Partner and Executive Director, OneVentures Pty Ltd 


Dr Chris Nave, Managing Director, Brandon Capital Partners


Dr Amanda Gillon, Investment Manager, BioScience Managers


Yasser El-Ansary, CEO, AVCAL

ICMMB Plenary


Keynote speaker: Professor Eiji Matsuura, Okayama University, Japan

Harnessing disease-specific antibody and its variant in “theranostics” of cancer

10:20 - 10:50am

Morning tea

10:50 - 12:00pm

Partnering on Product design and development


Utilising Digital Health to deliver on the promise of Personalised Medicine: A case study of the Parkinson’s KinetiGraph™ and the benefits it provides to patients, partners and payors:  


Timothy I. Still, President and CEO, Global Kinetics Corporation 


Dr Nicholas Opie, Director and CTO, SmartStent 


Biomechanics and Computer modeling/simulation-Part 2


Keynote speaker: Prof Fong-Chin Su, National Cheng Kung University, Taiwan

Biomechanical Concepts for Rehabilitation of Knee Osteoarthritis Using a Novel Pinnacle Trainer


Siamak Nezami Doost, Swinburne University of Technology, Australia

Using computational fluid dynamics to visualize blood flow of a patient-specific left ventricle


Tejas Canchi, Nanyang Technological University, Singapore

Effect of Patient History on Estimation of Rupture Risk in Asian Abdominal Aortic Aneurysm (AAA) Patients Using Machine Learning Methods 

Bioprinting and Biofabrication


A/Prof Andrea J. O’Connor, The University of Melbourne, Australia

Magnetic Regulation of Forces and Cell Assembly for Tissue Engineering


Holger Pils, Bio-Strategy PTY Ltd, Australia

3D-Bio-Printing and Nano-Dispensing Devices for Tissue Engineering 


Kara Perrow, University of Wollongong, Australia

Changing the Treatment Paradigm: Ex vivo Assessment of Gemcitabine-Eluting Degradable Polymeric Fibres for the Treatment of Pancreatic Ductal Adenocarcinoma 


Collaboration for commercialisation


Chair: Dr Joanne Boag, Senior Manager, Intellectual Property and Commercialisation, MCRI 


Dr Samih Nabulsi, General Manager, Cook Australia


Bronwyn Le Grice, Co-Founder and CEO, ANDHealth 


Charlie Day, CEO, Office of Innovation and Science Australia

What is Goverment's Policy on medtech


Chair: Lorraine Chiroiu, Deputy CEO, AusBiotech


Andrew Wear, Director, Medical Technologies and Pharmaceuticals Department of Economic Development, Jobs, Transport and Resources 


Marco Baccanti, Chief Executive, Health Industries South Australia

Biomechanics and Computer modeling/simulation-Part 3


Keynote speaker: Prof Itsu Sen (Yi Qian), Macquarie University, Australia


Yuanyuan Dai, Macquarie University, Australia.

Hemodynamics Analysis for carotid artery before and after carotid endarterectomy 

Advances in stem cell therapies - Part 2


Keynote speaker: Prof Paul Verma, Monash Institute of Medical Research, Australia


Nagarajan Ganapathy, Indian Institute of Technology, India

Emotion Analysis using Electrodermal Activity signals and Dynamic Restricted Boltzmann Machines

1:00 - 2:00pm


2:00 - 2:45pm

Risk process for Medical device Development and Commercialisation

How and why it is best to take a risk driven approach when commercialising technology. Presenting a case study: research developed at the University of Western Australia, taken through the commercialisation process into a start-up vehicle OncoRes, raising capital via Brand Capital


Keynote speaker: Toby McSweeney, Head of Class III Development Group, Hydrix




Chair: Toby McSweeney, Head of Class III Development Group, Hydrix


Liza Dunne, CEO, OncoRes Medical


Kath Giles, Investment Manager, Brandon Capital


Dr Brendan Kennedy

Laboratory Head, Harry Perkins Institute of Medical Research & Senior Research Fellow, The University of Western Australia & Chief Scientific Officer, OncoRes Medical.


ICMMB Plenary


Keynote speaker: Prof Anthony Weiss, University of Sydney, Australia

2:45 - 3:25pm

Update on the Federal Government Growth Centre


Sue MacLeman, Managing Director and CEO, MTPConnect


Michael Grogan, Victorian Director, Advanced Manufacturing Growth Centre 


Advances in medical devices - Design and optimisation


Keynote speaker: Dr Dan Abrams, Cerebral Therapeutics 

Creating Value in Central Nervous System startups


Don Bombuwela, Swinburne University of Technology, Australia

Improved Wireless Cyclic Pressure Ventricular Assist Device (Cy-VAD)


Philip Kinsella, Swinburne University of Technology, Australia

Automated Design of Custom-Fit In-Ear Devices from 3D Scan Data 




Paul R. Stoddart, Swimburne University of Technology, Australia

Dynamic Mechanical Properties of PDMS Measured on the Mesoscale with an Optical Fibre Sensor


Daniela Duc, Swinburne University of Technology, Australia

Fabrication of Gold Nanorod conjugated Reduced Graphene Oxide for Optical and Electrical Cell Co-Stimulation 


Xian Wen Tan, Okayama University, Japan

Natural Ameliorative Biomaterial for Oxidative Stress and Inflammation 


3:25 - 4:45pm

Frost & Sullivan 

Report on the Medtech sector

Mark Dougan, Consulting Director, Healthcare, Frost & Sullivan, Asia Pacific 

3:45 - 4:15pm

Afternoon tea

4:15 - 5:15pm

On the couch ICMMB & AusMedtech wrap-up session 

5:15 - 6:15pm

Closing Drinks

supported by: